Welcomes you to the “5th International Congress on Chronic Obstructive Pulmonary Disease” to be held on 25-26 June 2018, at Amsterdam, Netherlands.
COPD Congress 2018 is organized around the theme: “Learn more about COPD to overcome the obstacle: Breathe better, Live more”.
Allied Academies was founded by Jim and JoAnn Carland and the headquarters is located in North Carolina in United States of America. It conducts several academic conferences each year in different locations with internet participation possibilities for those who are physically unable to attend the conferences. Conference registrants are eligible for the Accelerated Journal Review. To provide you with maximum outlets for your research, Allied Business Academies holds joint meetings of all its member academies. In 1994 they launched the Journal of the International Academy of Case Studies, which has become a leader in publishing classroom teaching cases in business.
Why to attend COPD Congress 2018?
COPD Congress 2018 gives an exciting opportunity to meet with likeminded individuals and industry peers. Congress unites individuals from all different geographical areas who share a common discipline or field. Congress gives you the opportunity to converse with these individuals one-on-one about what they are really going after, and they may even give you guidance on how to enhance your own particular work. At conference you have the opportunity to get feedback on your work from individuals who have never seen it before and may provide new insight.
• Obstructive Lung Disease
• Chronic bronchitis
• Congestive Heart failure
• Lung cancer
• Stages and causes of COPD
• Interstitial lung disease
• Respiratory failure and Reactive Airway disease
• Sleep Medicine
• Alpha-1 Antitrypsin Deficiency
• COPD Disease severity and staging
• Risk of stroke
• Cystic Fibrosis
• Pleurisy and Other Pleural Disorders
• Lung Function Tests
• Environmental Pulmonary Diseases
• Pulmonary Disorders
• Chest Physiotherapy
Contact this user: Email:
(Use contact form below)
It is NOT ok to contact this poster with commercial interests.